CA
ABBV icon

Crewe Advisors’s AbbVie ABBV Stock Holding History

Crewe Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750K Buy
2,981
+297
+11% +$63.9K 0.05% 107
2026
Q1 		$584K Buy
2,684
+87
+3% +$19.3K 0.05% 115
2025
Q4 		$593K Buy
2,597
+27
+1% +$6.15K 0.05% 109
2025
Q3 		$595K Buy
2,570
+111
+5% +$22.6K 0.06% 108
2025
Q2 		$456K Buy
2,459
+15
+0.6% +$2.79K 0.06% 96
2025
Q1 		$512K Sell
2,444
-212
-8% -$41.2K 0.07% 77
2024
Q4 		$472K Sell
2,656
-756
-22% -$139K 0.07% 79
2024
Q3 		$674K Buy
3,412
+19
+0.6% +$3.55K 0.08% 68
2024
Q2 		$582K Buy
3,393
+199
+6% +$33K 0.07% 94
2024
Q1 		$582K Buy
+3,194
New +$550K 0.07% 88
2023
Q3 		– Sell
-2,642
Closed -$356K – 583
2023
Q2 		$356K Sell
2,642
-665
-20% -$97.5K 0.05% 98
2023
Q1 		$527K Sell
3,307
-13
-0.4% -$1.99K 0.08% 82
2022
Q4 		$537K Buy
3,320
+1,026
+45% +$157K 0.09% 74
2022
Q3 		$308K Buy
2,294
+863
+60% +$124K 0.06% 104
2022
Q2 		$219K Buy
1,431
+1,331
+1,331% +$203K 0.05% 119
2022
Q1 		$16K Hold
100
– – ﹤0.01% 315
2021
Q4 		$14K Buy
100
+17
+20% +$2.01K ﹤0.01% 297
2021
Q3 		$9K Hold
83
– – ﹤0.01% 271
2021
Q2 		$9K Hold
83
– – ﹤0.01% 283
2021
Q1 		$9K Hold
83
– – ﹤0.01% 295
2020
Q4 		$9K Sell
83
-52
-39% -$5K ﹤0.01% 273
2020
Q3 		$12K Buy
+135
New +$12.7K 0.01% 225
2018
Q4 		– Sell
-75
Closed -$7K – 226
2018
Q3 		$7K Sell
75
-150
-67% -$14.2K 0.01% 202
2018
Q2 		$21K Sell
225
-125
-36% -$12.2K 0.02% 172
2018
Q1 		$33K Buy
350
+348
+17,400% +$38.2K 0.03% 143
2017
Q4 		$0 Buy
+2
New +$188 ﹤0.01% 267

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Crewe Advisors's ABBV Position: Q2 2026 in Review

Crewe Advisors increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $63.9K and bringing the position to 2,981 shares worth $750K. The position accounts for 0.05% of the portfolio, ranked #107.

Crewe Advisors first reported a position in ABBV in Q4 2017 and has held it in 26 quarters since. 2,675 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Crewe Advisors held 2,981 shares of AbbVie worth $750K as of Q2 2026.
  • Crewe Advisors bought 297 AbbVie shares in Q2 2026, an estimated $63.9K.
  • AbbVie made up 0.05% of Crewe Advisors's portfolio in Q2 2026, its #107 holding.
  • Crewe Advisors first reported a position in AbbVie in Q4 2017 and has held it in 26 quarters since.
  • 2,675 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.